Financial Report Insights

QS — Q3 2026 Financial Report Analysis

Q3 · Fiscal year 2026 · Published by Pham Hop

QuantumScape had no revenue and narrowed its Q3 2026 net loss 20% to $84.5M, mostly through lower non-cash charges; it held $819.8M in cash and investments, and PowerCo paused milestone payments while the two renegotiate.

At a glance

  • $819.8 million in cash and investments at September 30, down $151.0 million since December 31. At the nine-month cash outflow rate, that lasts roughly three more years without new money.
  • The loss shrank 20%, but cash operating costs fell only about 2%. Once stock-based pay, depreciation and equipment write-offs are taken out, quarterly operating costs were $60.7 million against $62.1 million a year ago.
  • PowerCo payments are on hold. QuantumScape received $28.9 million from PowerCo this year, but under the October amendment no milestone payments will be made while the two sides renegotiate scope and payments.
Revenue
$0K
Net income
-$85M
Diluted EPS
-$0.14

Smaller loss, flat cash spending, and a pause in Volkswagen's milestone payments

QuantumScape is developing a solid-state lithium-metal battery for electric vehicles: a cell that replaces the liquid electrolyte between the two electrodes with a thin ceramic separator, aiming to store more energy in the same space and charge faster than today's lithium-ion cells. It has no products on sale yet, so in its third quarter of 2026 (July–September) it again reported no revenue and a net loss of $84.5 million, down 20% from $105.8 million a year earlier. Almost all of that improvement came from non-cash items. Operating spending in cash terms was flat. The bigger news is in the notes: on October 21 the company agreed with PowerCo, Volkswagen's battery company, to drop $7.0 million in scheduled payments, stop milestone payments and renegotiate the program that is QuantumScape's main route to selling its technology.

The numbers

QuantumScape's loss is mostly research and development (R&D): engineers, materials and the San Jose pilot production line. "Loss per share" is the net loss divided by the average number of shares outstanding.

MetricQ3 2026Q3 2025YoY Change
RevenueNoneNonen/a (pre-revenue)
Research and development$73.9M$92.1M-20%
General and administrative$18.5M$22.9M-19%
Total operating expenses$92.4M$115.0M-20%
Interest income$8.1M$10.0M-19%
Net loss-$84.5M-$105.8MLoss 20% smaller
Basic and diluted loss per share-$0.14-$0.18Loss per share 22% smaller
Weighted-average shares620.6M588.7M+5.4%
Stock-based compensation (non-cash)$16.3M$29.2M-44%
Operating cash outflow (nine months)$171.3M$186.3M-8%
Capital spending (nine months)$19.0M$24.0M-21%

Balance sheet, September 30, 2026 vs December 31, 2025:

ItemSep 30, 2026Dec 31, 2025Change
Cash, cash equivalents and marketable securities$819.8M$970.8M-$151.0M
Total liabilities$123.7M$139.2M-$15.4M
Stockholders' equity$995.3M$1,169.0M-$173.6M

Standard profitability ratios don't apply here. With zero revenue there is no operating margin to compute, and a percentage change in a loss says little about whether the technology is getting closer to market. For a company at this stage, the figures that matter are how fast cash is being used, how long it lasts, and whether partners are paying for progress. This report focuses on those.

Where the lower loss came from

Total operating expenses fell $22.6 million year over year. The 10-Q's explanation of the R&D decline lists, in order: $6.8 million less in impairment loss (write-downs of equipment with no further use), $6.8 million less in stock-based compensation, $1.3 million less in outside service fees and $0.9 million less in expensed equipment. G&A fell mainly because stock-based compensation dropped $6.1 million, partly offset by $1.1 million more in professional fees and office costs.

The filing's segment note breaks out the large non-cash items, which makes the cash picture easy to see:

Q3 operating expenses20262025
Total operating expenses$92.4M$115.0M
less stock-based compensation$16.3M$29.2M
less depreciation and amortization$12.7M$14.2M
less write-off of property and equipment$2.7M$9.5M
Remaining (mostly cash) costs$60.7M$62.1M

Personnel costs were $33.4 million in both quarters. On a nine-month basis the same calculation gives $188.2 million in 2026 against $189.7 million in 2025, almost unchanged. QuantumScape is not cutting its underlying spending. The headline loss fell because less stock-based pay was booked and fewer assets were written off.

What the headline numbers hide

A reversal of stock-based pay tied to missed milestones. QuantumScape pays part of its management in "Milestone PSUs", share awards that vest only if specific product-development and commercial milestones are reached by deadlines in May 2027, May 2028 and May 2029. In Q3 the company reversed $8.1 million of expense it had already booked for these awards ($2.9 million in R&D, $5.2 million in G&A) because management "determined, during the three months ended September 30, 2026, [they] were not probable of achievement." That turned Milestone PSU expense into a $4.2 million credit for the quarter, which lowered the reported loss. Another $14.8 million of unrecognized expense relates to milestones currently judged not probable. In plain terms, management's own accounting says that some internal targets set for this period are now unlikely to be met within the award windows. The filing does not say which milestones.

Cash use and runway. In the first nine months, operating cash outflow was $171.3 million and capital spending was $19.0 million: $190.4 million in total, or about $63 million a quarter. "Cash runway" is how long existing cash lasts at the current rate of spending. At about $254 million a year, $819.8 million covers roughly three and a quarter years, into late 2029, assuming no new money and no rise in spending. The 10-Q says cash is sufficient "for at least twelve months," which is the minimum disclosure standard. It also says R&D expenses are expected to "increase significantly for the foreseeable future". That conflicts with the 20% R&D decline this quarter, and if spending does rise, the runway shortens.

Interest income is shrinking. QuantumScape earned $8.1 million in interest on its cash in Q3, down from $10.0 million, "mainly due to the decrease in interest rates." That covers about 9% of operating costs. Lower rates, together with a smaller cash balance, will reduce this cushion further.

Dilution has slowed but continues. Last year QuantumScape sold 29.5 million new shares through an "at-the-market" program (selling stock gradually into the market) for $264.2 million. It sold none in 2026. The weighted-average share count still rose 5.4% year over year, partly because of those 2025 sales and partly because employee awards keep adding shares: 13.6 million shares were issued in the first nine months as restricted stock units vested. That is why loss per share fell 22% while the net loss fell 20%. A further $183.4 million of stock-based compensation not yet recognized ($150.3 million in RSUs, $33.1 million in PSUs judged probable) will keep adding shares over the next two to three years.

PowerCo money is not revenue. The $18.5 million PowerCo paid in Q3 ($28.9 million year to date) does not appear on the income statement. Because Volkswagen owns about 27.3% of QuantumScape's voting power, the payments are recorded directly in equity as a "capital contribution," with no shares issued. They lower net cash use, but they would not show up as sales even when progress is being made.

The PowerCo renegotiation

PowerCo is the battery company wholly owned by the Volkswagen Group. The collaboration is QuantumScape's main commercial path. PowerCo would industrialize QuantumScape's first product, the QSE-5 cell (about 5 amp-hours, over 800 Wh/L energy density, 10%-to-80% charge in under 15 minutes), and, once milestones are met, sign a license agreement that includes a $130 million royalty prepayment. That is a "capital-light" model: QuantumScape licenses its technology instead of building large factories itself.

The terms have changed twice in four months:

  • July 2026: the cost-reimbursement structure was replaced with transition payments plus payments for milestones such as delivering and validating battery cells over the next two years. The maximum total was $75.4 million, including amounts already paid.
  • October 21, 2026 (disclosed in this 10-Q in place of a separate 8-K): the parties removed $7.0 million in transition payments, reducing that maximum. They agreed to negotiate a revised scope of work and payments covering "our current and next generation technology roadmap and applications beyond automotive such as data centers or robotics." During this negotiation period, PowerCo will not make milestone payments for the Project.

The filing gives no explanation for the change and no timeline for the talks. What it does show is that the near-term payment stream from QuantumScape's main partner has stopped, and that the scope now explicitly includes markets outside cars. Read together with the Milestone PSU reversal, it suggests that the program schedule agreed in July is being reset. The $130 million license prepayment still depends on milestones being met.

Takeaway: The 20% smaller loss is mostly accounting: less stock-based pay booked, fewer write-offs, and an $8.1 million reversal because management now judges some development milestones unlikely to be met. Cash operating costs are flat at about $61 million a quarter, and the main partner has paused milestone payments while it renegotiates. That leaves QuantumScape's roughly three-year cash runway as the main protection while the timeline is reset.

What to watch next

  • The outcome of the PowerCo talks. The key questions are whether the revised agreement keeps a path to the $130 million license prepayment, what the new milestones and payments are, and how much of the scope moves from cars to data centers or robotics.
  • Pilot-line output. The automated pilot line in San Jose was inaugurated in February 2026 and is still ramping up. Its job is to supply QSE-5 cells for customer testing and technology transfer. Signs of higher cell volumes, or of the first QSE-5 production from the line, are the most direct evidence of progress.
  • Cash use against the R&D guidance. Management expects R&D to rise "significantly," but it fell 20% this quarter. If cash costs stay near $61 million a quarter, the runway lasts into late 2029. A step-up, or a resumed at-the-market share sale, would change that math.
  • More milestone reversals. If the next 10-K reverses more Milestone PSU expense, or the May 2027 tranche lapses, that would confirm that development is behind the original schedule.

Figures are from QuantumScape's Form 10-Q for the quarter ended September 30, 2026, filed October 23, 2026. The runway estimate and the cash-cost subtotal are our calculations from the filing's own figures.

Read 0 community reports on QuantumScape Corporation, or write your own.Write a report